IP Library Granted Patent US 9,952,204
Granted Patent B2
US 9,952,204 · App. 13/102,672 · Granted Apr 24, 2018

Formation of neuromuscular junctions in a co-culture comprising rat muscle cells overlayered with differentiated human spinal cord stem cells in a serum free medium

Inventors: James Hickman (Orlando, FL); Xiufang Guo (Oviedo, FL); Mercedes Gonzalez (Casselberry, FL); Maria Stancescu (Oviedo, FL)
Assignee: University of Central Florida Research Foundation, Inc.
G01N33/5058C12N5/0697G01N33/48728G01N33/6872G01N33/6887C12N2500/90C12N2501/01C12N2501/105C12N2501/13C12N2501/385C12N2501/41C12N2501/58C12N2502/081C12N2502/1335C12N2533/20C12N2535/10G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,952,204
App. No.
13/102,672
Granted
Apr 24, 2018
Kind
B2
Abstract

A method for forming neuromuscular junctions includes forming functional neuromuscular junctions between motoneurons and muscle cells by co-culturing one or more human motoneurons and one or more rat muscle cells in a substantially serum-free medium. A synthetic mammalian neuromuscular junction includes a human motoneuron functionally linked to a rat muscle cell in a substantially serum-free medium. An artificial substrate may be used to support the one or more neuromuscular junctions.

Claims (24)

1. A co-culture for forming at least one synthetic mammalian neuromuscular junction, comprising: rat skeletal muscle cells adhered to an artificial surface and overlayered with differentiated human spinal cord stem cells in a serum-free medium comprising retinoic acid (RA), cyclic AMP (cAMP), creatine, estrogen, and cholesterol, wherein the artificial surface comprises a silicon based monolayer substrate deposited thereon.

2. The co-culture of claim 1 , wherein one or more of the differentiated human spinal cord stem cells is functionally linked to one or more of the rat skeletal muscle cells.

3. The co-culture of claim 1 , wherein the silicon based monolayer substrate is deposited in a predetermined pattern.

4. The co-culture of claim 1 , wherein the serum-free medium comprises the components in Table 1.

5. The co-culture of claim 1 , wherein the serum-free medium comprises at least one synaptogenesis promoting component and one or more trophic factors.

6. The co-culture of claim 1 , wherein the serum-free medium further comprises the components listed in Table 2, the components listed in Table 3, and the components listed in Table 4.

7. The co-culture of claim 1 , wherein the silicon based monolayer substrate comprises trimethoxysilylpropyldiethylenetri-amine (“DETA”).

8. A method for forming at least one synthetic neuromuscular junction, the method comprising:

co-culturing rat skeletal muscle cells adhered to an artificial surface and overlayered with differentiated human spinal cord stem cells in a serum-free medium; and

forming at least one functional neuromuscular junction between a rat skeletal muscle cell and a differentiated human spinal cord stem cell,

wherein the serum-free medium comprises retinoic acid (RA), cyclic AMP (cAMP), creatine, estrogen, and cholesterol, and

wherein the artificial surface comprises a silicon based monolayer substrate deposited thereon.

9. The method of claim 8 , wherein the serum-free medium comprises at least one synaptogenesis promoting component and one or more trophic factors.

10. The method of claim 8 , wherein the silicon based substrate monolayer comprises DETA.

11. The method of claim 8 , wherein the silicon based substrate monolayer is deposited on the artificial surface in a predetermined pattern.

12. A method of forming synthetic neuromuscular junctions, the method comprising:

adhering rat skeletal muscle cells onto an artificial surface;

overlayering differentiated human spinal cord stem cells onto the rat skeletal muscle cells;

culturing the artificial surface in a serum-free medium, and

monitoring for formation of functional neuromuscular junctions,

wherein the serum-free medium comprises retinoic acid (RA), cyclic AMP (cAMP), creatine, estrogen, and cholesterol, and

wherein the artificial surface comprises a silicon based monolayer substrate deposited thereon.

13. The method of claim 12 , wherein the artificial surface is coated with DETA.

14. The method of claim 12 , wherein the serum-free medium comprises the components in Table 1.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2014
From: GONZALEZ, MERCEDES
To: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 032713/0258 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2014
From: HICKMAN, JAMES; GUO, XIUFANG; STANCESCU, MARIA
To: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 032568/0893 →
CONFIRMATORY LICENSE Recorded Aug 23, 2013
From: UNIVERSITY OF CENTRAL FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031076/0298 →
Continuity (4)
Continuation In Part 12765996 · Apr 23, 2010
Provisional Application 61331999 · May 6, 2010
Provisional Application 61171958 · Apr 23, 2009
Related Publication 20110250682A1 · Oct 13, 2011